Grant M. Comer, M.D.
Publications

Huynh TH, Johnson MW, Comer GM, Fish DN. Vitreous penetration of orally administered valacyclovir. Am J Ophthalmol 2008;145:682-686. Epub 2008 Jan 28.

Chong DY, Comer GM, Trobe JD. Optic disc edema, cystoid macular edema, and elevated vascular endothelial growth factor in a patient with POEMS syndrome. J Neuroophthalmol 2007;27:180-183.

Comer GM, Johnson MW.  Coats’ disease and retinal telangiectasis. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology, 3^rd ed. Philadelphia: WB Saunders [in press].

Comer GM, Ciulla TA, Criswell MH, Harris A. Exudative Age-Related Macular Degeneration. E-Medicine. Available at: http://www.emedicine.com/oph/topic653.htm.

Ciulla TA, Oliver A, Comer GM. MV-6401, a potent photosensitizer: a review of the current state of photosensitizing agents for the treatment of exudative age-related macular degeneration. Drugs of the Future 2005;30:1031-1038.

Ciulla TA, Comer GM, Peloquin C, Wheeler J. Human vitreous distribution of linezolid after a single oral dose. Retina 2005;25:619-624.

Comer GM, Danis RP. Optical coherence tomographic identification of retinal fold resolution in chronic hypotonous maculopathy after internal limiting membrane removal. Annals of Ophthalmology 2005;37:123-126.

Comer GM, Ciulla TA. Current and future pharmacological intervention for diabetic retinopathy. Expert Opin Emerg Drugs 2005;10:441-455.

Oliver A, Ciulla TA, Comer GM. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment. Curr Opin Ophthalmol 2005;16:160-165.

Comer GM, Ciulla TA, Heier JS, Criswell MH. Future pharmacological treatment options for non-exudative and exudative age-related macular degeneration. Expert Opin Emerg Drugs 2005;10:119-135.

Comer GM, Ciulla TA. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol2004;15:508-518.

Comer GM, Ciulla TA. Diagnostic imaging of retinal disease. Int Ophthalmol Clin 2004;44:1-15.

Comer GM, Ciulla TA, Criswell MH, Tolentino M. Current and future treatment options for non-exudative and exudative age-related macular degeneration. Drugs and Aging 2004;21:967-992.